by jdcline | Oct 27, 2019 | Biotech Investments, News
Dry Eye Treatment for an aging population EyeCyte provides amniotic membrane placement for those who suffer from chronic dry eye and 12 additional modalities through a network of specialty-trained doctors who have advanced training in amniotic disc placement on the...
by jdcline | Oct 2, 2019 | Biotech Investments, News
Long lasting severe dry eye treatment The latest treatment for dry eye syndrome in most cases will ne Prescription Eyedrops Tear Duct treatment Plugs Over the lat 10 users many eye surgeons have use amniotic membrane patch post operative to help the healing process....
by jdcline | Sep 22, 2019 | Biotech Investments
In-Office Use of Amniotic Membrane Human amniotic membrane (AM) has been shown to provide a substantial benefit in treating certain types of conjunctival and corneal disease. While AM has traditionally been transplanted using sutures or fibrin glue in an operating...
by jdcline | Jun 4, 2017 | Bioengineering, Biotech Investments, Biotechnology Companies, Biotechnology Jobs
stock overview [b2i_sec lo=”1″] [b2i_press_releases group=”1048″ c=”65″] [b2i_quote s=”your symbol”] [b2i_chart s=”your symbol”]
_______
